Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines

References

• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. J Am Coll Cardiol. 2014;63(25):2889–2934. doi:10.1016/j.jacc.2013.11.00224239923
   PubMed Web of Science ®Google Scholar
• Hayward RA, Krumholz HM. Three reasons to abandon low-density lipoprotein targets. Circ Cardiovasc Qual Outcomes. 2012;5(1):2–5. doi:10.1161/CIRCOUTCOMES.111.96467622253366
   PubMed Web of Science ®Google Scholar
• Maddox TM, Borden WB, Tang F, et al. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice. J Am Coll Cardiol. 2014;64(21):2183–2192. doi:10.1016/j.jacc.2014.08.04125447259
   PubMed Web of Science ®Google Scholar
• Lin I, Sung J, Sanchez RJ, et al. Patterns of statin use in a real-world population of patients at high cardiovascular risk. J Manag Care Spec Pharm. 2016;22(6):685–698. doi:10.18553/jmcp.2016.22.6.68527231796
   PubMedGoogle Scholar
• Wang WT, Hellkamp A, Doll JA, et al. Lipid testing and statin dosing after acute myocardial infarction. J Am Heart Assoc. 2018;7(3). doi:10.1161/JAHA.117.006460
   Web of Science ®Google Scholar
• Olufade T, Zhou S, Anzalone D, et al. Initiation patterns of statins in the 2 years after release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) cholesterol management guideline in a large US health plan. J Am Heart Assoc. 2017;6(5). doi:10.1161/JAHA.116.005205
   Web of Science ®Google Scholar
• Bellows BK, Olsen CJ, Voelker J, Wander C. Antihyperlipidemic medication treatment patterns and statin adherence among patients with ASCVD in a managed care plan after release of the 2013 ACC/AHA guideline on the treatment of blood cholesterol. J Manag Care Spec Pharm. 2016;22(8):892–900. doi:10.18553/jmcp.2016.22.8.89227459651
   PubMed Web of Science ®Google Scholar
• Tran JN, Kao TC, Caglar T, et al. Impact of the 2013 cholesterol guideline on patterns of lipid-lowering treatment in patients with atherosclerotic cardiovascular disease or diabetes after 1 year. J Manag Care Spec Pharm. 2016;22(8):901–908. doi:10.18553/jmcp.2016.22.8.90127459652
   PubMed Web of Science ®Google Scholar
• Okerson T, Patel J, DiMario S, Burton T, Seare J, Harrison DJ. Effect of 2013 ACC/AHA blood cholesterol guidelines on statin treatment patterns and low-density lipoprotein cholesterol in atherosclerotic cardiovascular disease patients. J Am Heart Assoc. 2017;6(3). doi:10.1161/JAHA.116.004909
   Web of Science ®Google Scholar
• Pokharel Y, Tang F, Jones PG, et al. Adoption of the 2013 American College of Cardiology/American Heart Association cholesterol management guideline in cardiology practices nationwide. JAMA Cardiol. 2017;2(4):361. doi:10.1001/jamacardio.2016.592228249067
   PubMed Web of Science ®Google Scholar
• Brown TM, Deng L, Becker DJ, et al. Trends in mortality and recurrent coronary heart disease events after an acute myocardial infarction among Medicare beneficiaries, 2001-2009. Am Heart J. 2015;170(2):249–255.e2. doi:10.1016/j.ahj.2015.04.02726299221
   PubMed Web of Science ®Google Scholar
• Levitan EB, Muntner P, Chen L, et al. Burden of coronary heart disease rehospitalizations following acute myocardial infarction in older adults. Cardiovasc Drugs Ther. 2016;30(3):323–331. doi:10.1007/s10557-016-6653-626898407
   PubMed Web of Science ®Google Scholar
• Faurot KR, Jonsson Funk M, Pate V, et al. Using claims data to predict dependency in activities of daily living as a proxy for frailty. Pharmacoepidemiol Drug Saf. 2015;24(1):59–66. doi:10.1002/pds.371925335470
   PubMed Web of Science ®Google Scholar
• R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2018.
   Google Scholar
• Virani SS, Pokharel Y, Steinberg L, et al. Provider understanding of the 2013 ACC/AHA cholesterol guideline. J Clin Lipidol. 2016;10(3):497–504.e4. doi:10.1016/j.jacl.2015.11.00227206936
   PubMed Web of Science ®Google Scholar
• Jacobson TA, Ito MK, Maki KC, et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 1 – full report. J Clin Lipidol. 2015;9(2):129–169. doi:10.1016/j.jacl.2015.02.00325911072
   PubMed Web of Science ®Google Scholar
• Pokharel Y, Akeroyd JM, Virani SS. Cholesterol guidelines: more similar than different. Prog Cardiovasc Dis. 2016;59(2):190–199. doi:10.1016/j.pcad.2016.07.01027497507
   PubMed Web of Science ®Google Scholar
• Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2019;73(24):e285–350. doi:10.1016/j.jacc.2018.11.00330423393
   PubMed Web of Science ®Google Scholar
• Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387–2397. doi:10.1056/NEJMoa141048926039521
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376(18):1713–1722. doi:10.1056/NEJMoa161566428304224
   PubMed Web of Science ®Google Scholar
• Schwartz GG, Steg PG, Szarek M, et al. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018;379(22):2097–2107. doi:10.1056/NEJMoa180117430403574
   PubMed Web of Science ®Google Scholar